Clinical trials
Observational Anxiety Disorders trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 3 |
| 2005 | 1 |
| 2006 | 1 |
| 2008 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 7 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 4 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Recruiting | 5 |
| Unknown status | 4 |
| Withdrawn | 2 |
| Not yet recruiting | 1 |
| Terminated | 1 |
| Enrolling by invitation | 1 |
| Active, not recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University of British Columbia | 3 |
| McMaster University | 2 |
| Nova Scotia Health Authority | 2 |
| University Health Network, Toronto | 2 |
| University of Regina | 2 |
| University of Saskatchewan | 2 |
| Bianca Horner | 1 |
| Daniel Benjamin | 1 |
| Empower Research Inc | 1 |
| Fraser Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Anxiety Disorders | 33 |
| Generalized Anxiety Disorder | 4 |
| Mood Disorders | 4 |
| Panic Disorder | 4 |
| Stress Disorders, Post-Traumatic | 4 |
| COVID-19 | 3 |
| Obsessive-Compulsive Disorder | 3 |
| Pain | 3 |
| Alcoholism | 2 |
| Depressive Disorder | 2 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.